Jazz Pharmaceuticals Announces First Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Jazz Pharmaceuticals Announces First Quarter 2020 Financial Results

Jazz Pharmaceuticals (JAZZ) Misses Q1 EPS by 22c; Lowers Outlook

May 5, 2020 4:17 PM EDT

Jazz Pharmaceuticals (NASDAQ: JAZZ) reported Q1 EPS of $0.45, $0.22 worse than the analyst estimate of $0.67. Revenue for the quarter came in at $534.73 million versus the consensus estimate of $544.55 million.

"During this unprecedented time, I am proud of the commitment of our Jazz employees to supporting the continued delivery of our essential medicines to patients around the world," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals. "Based on these efforts, we... More